Eisai Co., Ltd. (Headquarters: Tokyo, President: Haruo Naito), announced the January 13th launch of the JUSTAT family of products (JUSTAT COOL SPRAY, JUSTAT COOL GEL, JUSTAT CREAM, and JUSTAT SOLUTION), for the treatment of athlete's foot and ringworm.
Each product in the JUSTAT family contains bifonazole, an antifungal agent, with a strong fungicidal action on Trychophiton, which is effective against athlete's foot and ringworm in a once-daily dose, penetrating deep into the skin. The combined action of the other ingredients, such as crotamiton to relieve itching, lidocaine to control itching and pain, glycyrrhetinic acid to alleviate inflammation, and l-menthol to cool the affected area. These additional ingredients relieve the unpleasant symptoms associated with athlete's foot and ringworm.
According to a survey conducted by Eisai of 600 men and women of ages ranging from teens through sixties who use athlete's foot remedies, the average age at the onset of athlete's foot was 31.1 years old, and 74% of the users were in their thirties or younger. The survey revealed that there is a significant demand for products which offer a more attractive image and greater ease-of-use, especially from many younger people who are reluctant to use a medication for athlete's foot.
The JUSTAT family of products, including a handy COOL SPRAY and refreshing COOL GEL, are offered in a package design which communicates a fresh image to meet consumer needs and to be used regularly by an expanded user base including the young.